Nonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysis

Pain recurrence was reported by only three studies which could not be pooled: a higher proportion of patients treated with 75 mg diclofenac (IM) showed pain recurrence in the first 24 hours of follow-up compared to those treated with 40 mg piroxicam (IM) (60 participants: RR , 95% CI to ); no significant difference in pain recurrence at 72 hours was observed between piroxicam plus phloroglucinol and piroxicam plus placebo groups (253 participants: RR , 95% CI ); and there was no significant difference in pain recurrence within 72 hours of discharge between IM piroxicam and IV paracetamol (82 participants: RR , 95% CI to ).

Nonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysis

nonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysis

Media:

nonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysisnonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysisnonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysisnonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysisnonsteroidal anti-inflammatory drug use and the risk of melanoma a meta-analysis